Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.74 $2.44 Thursday, 9th May 2024 ERAS stock ended at $1.96. This is 8.84% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 10.51% from a day low at $1.95 to a day high of $2.16.
90 days $1.66 $2.66
52 weeks $1.51 $3.38

Historical Erasca, Inc. prices

Date Open High Low Close Volume
May 09, 2024 $2.14 $2.16 $1.95 $1.96 488 809
May 08, 2024 $2.18 $2.18 $2.10 $2.15 405 449
May 07, 2024 $2.22 $2.27 $2.17 $2.18 769 500
May 06, 2024 $2.16 $2.21 $2.10 $2.21 449 693
May 03, 2024 $2.22 $2.23 $2.11 $2.14 256 907
May 02, 2024 $2.11 $2.17 $2.03 $2.15 583 745
May 01, 2024 $2.02 $2.15 $1.99 $2.09 653 514
Apr 30, 2024 $2.01 $2.06 $1.95 $2.01 391 874
Apr 29, 2024 $1.92 $2.07 $1.89 $2.04 591 284
Apr 26, 2024 $1.90 $1.91 $1.85 $1.89 251 882
Apr 25, 2024 $1.85 $1.89 $1.81 $1.88 447 442
Apr 24, 2024 $1.95 $1.95 $1.86 $1.88 533 472
Apr 23, 2024 $1.85 $1.97 $1.85 $1.93 441 697
Apr 22, 2024 $1.79 $1.88 $1.79 $1.85 320 642
Apr 19, 2024 $1.77 $1.82 $1.74 $1.79 562 081
Apr 18, 2024 $1.82 $1.87 $1.76 $1.79 634 484
Apr 17, 2024 $1.93 $1.96 $1.84 $1.84 578 239
Apr 16, 2024 $2.00 $2.09 $1.91 $1.93 730 844
Apr 15, 2024 $2.11 $2.13 $1.97 $2.00 734 275
Apr 12, 2024 $2.27 $2.28 $2.08 $2.11 580 706
Apr 11, 2024 $2.22 $2.31 $2.22 $2.29 603 930
Apr 10, 2024 $2.23 $2.36 $2.19 $2.22 867 431
Apr 09, 2024 $2.25 $2.44 $2.24 $2.26 1 214 302
Apr 08, 2024 $2.11 $2.25 $2.08 $2.24 521 146
Apr 05, 2024 $2.08 $2.12 $2.04 $2.10 866 098
Click to get the best stock tips daily for free!

About Erasca, Inc.

Erasca. Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also ... ERAS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT